FDA
FDA Articles
Chimerix has announced that its lead drug candidate has been provided for potential use in patients with Ebola virus disease.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ:...
Published:
Alimera Sciences traded up big on Monday on news that the company received FDA approval for its diabetic macular edema drug Iluvien.
Published:
In the after-hours on Wednesday, Flexion Therapeutics made a hard fall on the news of a clinical hold.
Published:
NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the true underlying story.
Published:
ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical trial. The FDA has posted the briefing materials...
Published:
Prana Biotechnology saw its shares surge on Friday, on the heels of the FDA granting an orphan drug designation to the company’s PBT2.
Published:
Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockTekmira Pharmaceuticals Corp. (NASDAQ: TKMR)...
Published:
ThinkstockThe world is dealing with Ebola outbreaks and scares again. We are also in the midst of debates as to whether two Americans who contracted Ebola in Africa should have been brought back for...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockA brand new research report from RBC...
Published:
ThinkstockInvestors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at all that the biotech sector is full of all sorts of risks, making and taking...
Published:
A new report from the analysts at Cowen shows that, on average, biotech stocks gained 84% in the 12 months prior to an FDA approval and lost 24% in the 12 months after the approval.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockMannKind Corp. (NASDAQ: MNKD) has seen its...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.